Corrigendum: Probiotics for the treatment of docetaxel-related weight gain of breast cancer patients-A single-center, randomized, double-blind, and placebo-controlled trial

Front Nutr. 2023 Aug 22:10:1276556. doi: 10.3389/fnut.2023.1276556. eCollection 2023.

Zhang Juan¹, Zhang Qing², Liang Yongping³, Liyuan Qian², Wei Wu², Yanguang Wen², Jianbin Tong^{4

5

6}, Boni Ding²

¹ Department of Breast Surgery, Tangshan People's Hospital, Tangshan, Hebei, China.
² Department of Breast and Thyroid Surgery, Third Xiangya Hospital, Central South University, Changsha, China.
³ Department of Medical Imaging (Ultrasound), Tangshan Central Hospital, Tangshan, China.
⁴ Hunan Province Key Laboratory of Brain Homeostasis, Third Xiangya Hospital, Central South University, Changsha, China.
⁵ Center for Experimental Medicine, Third Xiangya Hospital, Central South University, Changsha, China.
⁶ Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China.

Abstract

[This corrects the article DOI: 10.3389/fnut.2021.762929.].

Keywords: breast cancer; docetaxel-based chemotherapy; docetaxel-related weight gain; gut microbiota; metabolism.